GB769757A - Improvements in or relating to the manufacture of sulfonamides - Google Patents

Improvements in or relating to the manufacture of sulfonamides

Info

Publication number
GB769757A
GB769757A GB13636/55A GB1363655A GB769757A GB 769757 A GB769757 A GB 769757A GB 13636/55 A GB13636/55 A GB 13636/55A GB 1363655 A GB1363655 A GB 1363655A GB 769757 A GB769757 A GB 769757A
Authority
GB
United Kingdom
Prior art keywords
radical
thiadiazole
anhydride
sulphonamide
propionyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB13636/55A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of GB769757A publication Critical patent/GB769757A/en
Expired legal-status Critical Current

Links

Abstract

2 - Acylamino - 1,3,4 - thiadiazole - 5 - sulphonamides of the general formula <FORM:0769757/IV(b)/1> wherein R1 is an acyl radical and R2 is then hydrogen, and when R1 and R2 are taken together they form the phthaloyl radical, are prepared by reacting 2-amino-1,3,4-thiadiazole-5-sulphonamide with the required carboxylic acid anhydride or acyl chloride. In the case of the anhydride reactants, the process may be carried out in the absence of solvents, a suitable reaction temperature using an anhydride reactant being 100 DEG to 200 DEG C., preferably 140 DEG to 180 DEG C. In the case of the acyl chloride reactants, the process is preferably carried out in the presence of an acid acceptor, e.g. pyridine, quinoline, triethylamine, tripropylamine or other tertiary aliphatic amine, or an inorganic base such as an alkali metal hydroxide, carbonate or bicarbonate. The group R1 may be a lower alkyl carbonyl radical such as a propionyl, acetyl, trifluoroacetyl, butyryl, isobutytyl, chloroacetyl, aminoacetyl, valeryl, or isovaleryl radical, or an aroyl radical such as the benzoyl radical. In the examples, the following compounds are prepared: 2-propionyl-, 2-acetylamino-, 2-trifluoroacetylamino-, 2-phthaloylamino-, 2-n-butyrylamino-, 2-chloroacetylamino-, 2-isovalerylamino-, 2-benzoylamino-, 2-isobutyrylamino-, and 2-[(N-carbobenzoxy) glycylamino] - 1,3,4 - thiadiazole - 5 - sulphonamide. Specification 687,760 is referred to.
GB13636/55A 1954-05-13 1955-05-11 Improvements in or relating to the manufacture of sulfonamides Expired GB769757A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US769757XA 1954-05-13 1954-05-13

Publications (1)

Publication Number Publication Date
GB769757A true GB769757A (en) 1957-03-13

Family

ID=22135372

Family Applications (1)

Application Number Title Priority Date Filing Date
GB13636/55A Expired GB769757A (en) 1954-05-13 1955-05-11 Improvements in or relating to the manufacture of sulfonamides

Country Status (1)

Country Link
GB (1) GB769757A (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004017964A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
WO2007062314A2 (en) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Heterocyclic cetp inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
EP2392567A1 (en) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Benzothiazine derivatives and their use as lxr modulators
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof
CN111646954A (en) * 2020-07-22 2020-09-11 双鹤药业(商丘)有限责任公司 Novel acetazolamide crystal form and preparation method thereof

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004017964A1 (en) 2002-08-19 2004-03-04 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
EP2392567A1 (en) 2005-10-21 2011-12-07 Bristol-Myers Squibb Company Benzothiazine derivatives and their use as lxr modulators
WO2007062314A2 (en) 2005-11-23 2007-05-31 Bristol-Myers Squibb Company Heterocyclic cetp inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
WO2014170786A1 (en) 2013-04-17 2014-10-23 Pfizer Inc. N-piperidin-3-ylbenzamide derivatives for treating cardiovascular diseases
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof
CN111646954A (en) * 2020-07-22 2020-09-11 双鹤药业(商丘)有限责任公司 Novel acetazolamide crystal form and preparation method thereof

Similar Documents

Publication Publication Date Title
GB769757A (en) Improvements in or relating to the manufacture of sulfonamides
DE3264656D1 (en) Process for the production of a peroxy compound
GB1113618A (en) 3-hydroxyisoazole derivatives
GB1123929A (en) Unsaturated sulphonic acid betaines and a process for their production
US3435048A (en) Process for preparing 5-aryl-3-aminoisoxazoles
GB952477A (en) Improved process for obtaining ª‡-ª‰, ª€-ªŠ unsaturated carboxylic esters
US2806036A (en) Process for preparation of
GB959420A (en) Oxyalkylated carboxylic acid amides and production thereof
US2477869A (en) Nitro sulfonates from beta-nitro alkanols
SU632302A3 (en) Method of producing 1,3,4-thiadiazole-2-ylureas
US2921960A (en) Substituted amino-carboxylic acid amides and method of making the same
GB1085038A (en) Process for the manufacture of n-acyl taurides
GB787061A (en) Process for producing n-methyl--a-phenylsuccinimide
GB808304A (en) Thiophosphoric acid esters and their preparation
GB795458A (en) Derivatives of ª‡-amino-ª‰-hydroxy-acids and the manufacture thereof
GB798846A (en) N-picolinoyl-phthalic acid hydrazide
GB590040A (en) Improvements in and relating to the synthesis of thiazolines
GB728368A (en) Improvements in or relating to the production of 3-pyrazolidones
GB1364088A (en) 3-substituted-thio-methyl-3-cephem-4-carboxylic acid derivatives and preparation thereof
GB810646A (en) A process for the production of o.o-dialkylphosphoric or o.o-dialkylthionophosphoric acid esters of n-alkylol-lactams
GB801394A (en) 1:3:4-thiadiazoles and their preparation
GB853441A (en) Surface-active agents
GB1086038A (en) Unsaturated sulphonic acids
GB948882A (en) Process for preparing borazoles
GB836150A (en) New 3-amino-6-substituted pyridazines and preparation of sulfanilamidopyridazines therefrom